Fate Therapeutics Inc (FATE)

Investing Cash Flow

$14.56M

Quarterly · Period ending: · USD

FATE logo

FATE Investing Cash Flow

Latest reported$14.56M
FATE Quarterly Cash from Investing (-$355.00K → $14.56M)
High-resolution chart · PNG

FATE investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Fate Therapeutics Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
14,557,000
23,587,000
27,630,000
21,272,000
19,591,000
42,673,000
22,816,000
25,461,000
-53,373,000
17,314,000
45,353,000
24,805,000
33,167,000
9,340,000
53,112,000
80,378,000
40,287,000
-7,026,000
71,278,000
77,959,000
-1,372,000
-471,888,000
-166,029,000
-54,141,000
35,320,000
23,774,000
-110,516,000
36,286,000
-91,977,000
8,754,000
16,383,000
13,276,000
13,722,000
-43,844,000
13,203,000
13,638,000
1,339,000
-38,376,000
5,978,000
458,000
5,794,000
-16,344,000
-178,000
-655,000
-213,000
-452,000
-271,000
-187,000
-26,000
-398,000
-150,000
-17,000
-64,000
-7,000
-295,000
-355,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.